Dr Aronson, in a paper on Factor IX concentrates, referenced the high number of cases reported of icteric hepatitis in Factor IX concentrates. A survey of sera from haemophilia B patients revealed that the overwhelming majority of patients treated with Factor IX concentrates had markers indicating prior infection with HBV.